^Myler P; Fasel N, ур. (2008). Leishmania: After The Genome. Caister Academic Press. ISBN978-1-904455-28-8.
^Ansari MY, Equbal A, Dikhit MR, Mansuri R, Rana S, Ali V, Sahoo GC, Das P (2015). „Establishment of Correlation between In-Silico &In-Vitro Test Analysis against Leishmania HGPRT to inhibitors”. International Journal of Biological Macromolecules. 83: 78—96. PMID26616453. doi:10.1016/j.ijbiomac.2015.11.051.
Ansari MY, Dikhit MR, Sahoo GC, Das P (2012). „Comparative modeling of HGPRT enzyme of L. donovani and binding affinities of different analogs of GMP”. Int J Biol Macromol. 50 (3): 637—49. PMID22327112. doi:10.1016/j.ijbiomac.2012.01.010.
The International Leishmania Network (ILN)Архивирано на сајту Wayback Machine (22. септембар 2017) has basic information on the disease and links to many aspects of the disease and its vector.
A discussion list (Leish-L) is also available with over 600 subscribers to the list, ranging from molecular biologists to public health workers, from many countries both inside and outside endemic regions. Comments and questions are welcomed.
KBD: Kinetoplastid Biology and Disease, is a website devoted to leishmaniasis, sleeping sickness and Chagas disease (American trypanosomiasis). It contains free access to full text peer-reviewed articles on these subjects. The site contains many articles relating to the unique kinetoplastid organelle and genetic material therein.
